Linagliptin N-Acylated Aminoaryl Impurity

Linagliptin N-Acylated Aminoaryl Impurity Or N-(2-acetylphenyl)-2-(8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,4,5,6,7-hexahydro-1H-purin-1-yl)acetamide, It is an impurity of Linagliptin, It is an dipeptidyl peptidase-4 inhibitors, which improve glycemic control in adults with type-2 diabetes. it is GLP-1 and GIP stimulates the release of insulin from beta cells.

Additional information on Linagliptin N-Acylated Aminoaryl Impurity

Catalogue No.

VE009584

CAS No.

N/A

Molecular Formula

C25H31N7O4

Molecular Weight

493.56 g/mol

Parent drug

Linagliptin

IUPAC Name

N-(2-acetylphenyl)-2-(8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2, 6-dioxo-2, 3, 4, 5, 6, 7-hexahydro-1H-purin-1-yl)acetamide

Synonyms

N-Desmethyl

References

McGill, J. B. (2012). Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials. Therapeutic Advances in Endocrinology and Metabolism, 3(4), 113–124. https://doi.org/10.1177/2042018812449406

Status

In-stock